NEW YORK, October 18, 2016 /PRNewswire/ --
Highly intuitive user interface, combined with the deepest indexing and extraction of relevant chemistry literature and data, marks new gold standard for chemistry information tools
Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced
"Whether in pharmaceutical drug discovery, chemical product development or education, chemists rely on technology solutions more and more to deliver answers on-demand as the volume of published research grows daily," said Thibault Geoui, Senior Director of Solution Marketing, Elsevier R&D Solutions. "And yet, most chemistry tools are sub-optimal because you have to be an expert user to get what you need. The average chemist spends 5-10 hours a week hunting for relevant data. It's inefficient. Reaxys addresses this challenge head-on by delivering answers to every user faster than any other solution, and faster with every iteration."
Built by chemistry, content and technology experts, the new Reaxys raises the standard in speed and simplicity for all chemistry tools in the market. It introduces improvements that are particularly useful for novice users while also enhancing the capabilities that experienced users rely on:
Beta testers have confirmed that the new Reaxys is the next generation for chemistry search. Gunther Kurapkat, Senior Vice President, Life Science Solutions, Elsevier R&D Solutions, said, "Modern chemistry information tools are complex to build - requiring not just chemistry and content expertise, but also innovative use of technology and nimble product development to quickly respond to market feedback. We will keep raising standards for how chemists' information needs are served, and we're proud to be responding to market needs first, more often and much faster than our less agile competitors. At our pace, other solutions will increasingly lag behind ever-evolving customer needs and technologies."
With this latest release, Reaxys now contains over 240 years of unparalleled chemistry content, including: 105 million organic, inorganic and organometallic compounds, 41 million chemical reactions, 500 million published experimental facts, 16,000 chemistry related periodicals, and six indexing sources for a cross-disciplinary view of chemistry. For more information on Reaxys, visit www.elsevier.com/reaxys .
To further support overcoming bottlenecks in chemistry research, the 2016 #ChemSearch Challenge - chemsearch.elsevier.com - also launches this week, this time allowing not just Reaxys customers but also non-customers to test-drive all that Reaxys has to offer as they compete to solve weekly challenges.
Reaxys is a trade mark of RELX Intellectual Properties SA, used under license.
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions - among them ScienceDirect, Scopus, Research Intelligence and ClinicalKey - and publishes over 2,500 journals, including The Lancet and Cell, and more than 35,000 book titles, including a number of iconic reference works. Elsevier is part of RELX Group, a world-leading provider of information and analytics for professional and business customers across industries. www.elsevier.com
Media contact Christopher Capot Director, Corporate Relations, Elsevier +1 917 704 5174 firstname.lastname@example.org
Subscribe to our Free Newsletters!
Pterygium or Surfer's eye is described as a proliferative disorder of the ocular surface possibly ...
Ecchymosis is a flat, discolored patch of skin that occurs when there is bleeding underneath; it is ...
Age related macular degeneration is a disease of the elderly, wherein the macula or the central ...View All